AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, Y.
Right arrow Articles by Lee, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, Y.
Right arrow Articles by Lee, W. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.3297
AJR 2008; 191:215-220
© American Roentgen Ray Society


Original Research

Growth Rate of New Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation: Evaluation with Multiphase CT

Yulri Park1, Dongil Choi, Hyo K. Lim, Hyunchul Rhim, Young-sun Kim, Seong Hyun Kim and Won Jae Lee

1 All authors: Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-Dong, Kangnam-Ku, Seoul 135-710, Republic of Korea.

OBJECTIVE. The purpose of this study was to evaluate with serial follow-up CT examinations the growth rate of new hepatocellular carcinoma (HCC) developing after percutaneous radiofrequency ablation and to determine an appropriate follow-up interval for imaging.

MATERIALS AND METHODS. Sixty-two new HCCs appearing after percutaneous radiofrequency ablation in 59 patients who underwent follow-up multiphase CT were retrospectively identified. The volume of the new HCCs at follow-up CT was measured on a PACS monitor with an area measuring tool and summation-of-areas technique. We calculated tumor volume doubling time and tumor diameter doubling time. The growth rate was represented by tumor volume doubling time. We also used stepwise multiple linear regression analysis to evaluate the relation between clinical variables and tumor volume doubling time.

RESULTS. Mean baseline and follow-up tumor volumes were 580 mm3 (range, 85–13,861 mm3) and 2,072 mm3 (range, 535–35,937 mm3). Mean baseline and follow-up tumor diameters were 9.9 mm (range, 5.5–29.8 mm) and 15.0 mm (range, 10.1–40.9 mm). Mean tumor volume and tumor diameter doubling times were 75 days (range, 21–209 days) and 219 days (range, 57–897 days). Volume doubling times of baseline tumors with a diameter of 1 cm or less were significantly shorter than those of the larger baseline tumors (mean, 55 vs 88 days; p = 0.024).

CONCLUSION. The growth rate of new HCCs after percutaneous radiofrequency ablation was higher than that reported in natural outcome studies of untreated HCCs. The results of our study suggest that a shorter follow-up interval for imaging, 2.5 months (75 days), is appropriate.

Keywords: helical CT • hepatocellular carcinoma • radiofrequency ablation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
J.-S. Yu, K. W. Kim, D. G. Mitchell, D. Choi, S. K. Verma, D. Bergin, H.-W. L. Hann, and S. K. Herrine
Hepatocellular Carcinoma: Progression in Patients with Hepatitis B versus C Virus Infection
Radiology, December 1, 2008; 249(3): 1082 - 1083.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.